133 related articles for article (PubMed ID: 30142120)
1. Prediction and Management for Relapse of Type 1 Autoimmune Pancreatitis After Initial Steroid Treatment: A Long-Term Follow-up From China.
Xin L; Meng QQ; Hu LH; Lin H; Pan J; Hao L; Liu PP; Qian W; Wang LW; Li ZS
Pancreas; 2018 Oct; 47(9):1110-1114. PubMed ID: 30142120
[TBL] [Abstract][Full Text] [Related]
2. Relapse rate and predictors of relapse in a large single center cohort of type 1 autoimmune pancreatitis: long-term follow-up results after steroid therapy with short-duration maintenance treatment.
Lee HW; Moon SH; Kim MH; Cho DH; Jun JH; Nam K; Song TJ; Park DH; Lee SS; Seo DW; Lee SK
J Gastroenterol; 2018 Aug; 53(8):967-977. PubMed ID: 29362937
[TBL] [Abstract][Full Text] [Related]
3. Autoimmune pancreatitis: pancreatic and extrapancreatic MR imaging-MR cholangiopancreatography findings at diagnosis, after steroid therapy, and at recurrence.
Manfredi R; Frulloni L; Mantovani W; Bonatti M; Graziani R; Pozzi Mucelli R
Radiology; 2011 Aug; 260(2):428-36. PubMed ID: 21613442
[TBL] [Abstract][Full Text] [Related]
4. Outcome of Long-term Maintenance Steroid Therapy Cessation in Patients With Autoimmune Pancreatitis: A Prospective Study.
Hirano K; Tada M; Isayama H; Sasahira N; Umefune G; Akiyama D; Watanabe T; Saito T; Takagi K; Takahara N; Hamada T; Mizuno S; Miyabayashi K; Mohri D; Kogure H; Yamamoto N; Nakai Y; Arizumi T; Toda N; Koike K
J Clin Gastroenterol; 2016 Apr; 50(4):331-7. PubMed ID: 26565969
[TBL] [Abstract][Full Text] [Related]
5. Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience.
Hart PA; Topazian MD; Witzig TE; Clain JE; Gleeson FC; Klebig RR; Levy MJ; Pearson RK; Petersen BT; Smyrk TC; Sugumar A; Takahashi N; Vege SS; Chari ST
Gut; 2013 Nov; 62(11):1607-15. PubMed ID: 22936672
[TBL] [Abstract][Full Text] [Related]
6. Correlation between long-term outcome and steroid therapy in type 1 autoimmune pancreatitis: relapse, malignancy and side effect of steroid.
Shimizu S; Naitoh I; Nakazawa T; Hayashi K; Miyabe K; Kondo H; Nishi Y; Yoshida M; Umemura S; Hori Y; Kato A; Okumura F; Sano H; Hirata Y; Takada H; Ohara H; Joh T
Scand J Gastroenterol; 2015; 50(11):1411-8. PubMed ID: 26061806
[TBL] [Abstract][Full Text] [Related]
7. Predictive Factors for Autoimmune Pancreatitis Relapse After 3 Years of Maintenance Therapy.
Nakamura A; Ozawa M; Watanabe T; Ito T; Muraki T; Hamano H; Koinuma M; Kawa S
Pancreas; 2018; 47(10):1337-1343. PubMed ID: 30286015
[TBL] [Abstract][Full Text] [Related]
8. Short-term and long-term outcomes of autoimmune pancreatitis.
Takuma K; Kamisawa T; Tabata T; Inaba Y; Egawa N; Igarashi Y
Eur J Gastroenterol Hepatol; 2011 Feb; 23(2):146-52. PubMed ID: 21287714
[TBL] [Abstract][Full Text] [Related]
9. Appropriate steroid therapy for autoimmune pancreatitis based on long-term outcome.
Kamisawa T; Okamoto A; Wakabayashi T; Watanabe H; Sawabu N
Scand J Gastroenterol; 2008; 43(5):609-13. PubMed ID: 18415756
[TBL] [Abstract][Full Text] [Related]
10. Clinical course of type 1 autoimmune pancreatitis patients without steroid treatment: a Japanese multicenter study of 97 patients.
Kubota K; Kamisawa T; Hirano K; Hirooka Y; Uchida K; Ikeura T; Shiomi H; Ohara H; Shimizu K; Arakura N; Kanno A; Sakagami J; Itoi T; Ito T; Ueki T; Nishino T; Inui K; Mizuno N; Yoshida H; Sugiyama M; Iwasaki E; Irisawa A; Okazaki K; Kawa S; Shimosegawa T; Takeyama Y; Chiba T
J Hepatobiliary Pancreat Sci; 2018 Apr; 25(4):223-230. PubMed ID: 29430861
[TBL] [Abstract][Full Text] [Related]
11. Impact of sclerosing dacryoadenitis/sialadenitis on relapse during steroid therapy in patients with type 1 autoimmune pancreatitis.
Ishii Y; Serikawa M; Sasaki T; Fujimoto Y; Yamaguchi A; Ogawa T; Noma B; Okazaki A; Yukutake M; Ishigaki T; Chayama K
Scand J Gastroenterol; 2019 Feb; 54(2):259-264. PubMed ID: 30915865
[TBL] [Abstract][Full Text] [Related]
12. Risk Factors for Rate of Relapse and Effects of Steroid Maintenance Therapy in Patients With Autoimmune Pancreatitis: Systematic Review and Meta-analysis.
Tacelli M; Celsa C; Magro B; Barresi L; Guastella S; Capurso G; Frulloni L; Cabibbo G; Cammà C
Clin Gastroenterol Hepatol; 2019 May; 17(6):1061-1072.e8. PubMed ID: 30312787
[TBL] [Abstract][Full Text] [Related]
13. Differences in clinical profile and relapse rate of type 1 versus type 2 autoimmune pancreatitis.
Sah RP; Chari ST; Pannala R; Sugumar A; Clain JE; Levy MJ; Pearson RK; Smyrk TC; Petersen BT; Topazian MD; Takahashi N; Farnell MB; Vege SS
Gastroenterology; 2010 Jul; 139(1):140-8; quiz e12-3. PubMed ID: 20353791
[TBL] [Abstract][Full Text] [Related]
14. [Relapsing autoimmune pancreatitis type 1: case report].
Ondrejková A; Kianička B; Nechutová H; Hruška L; Novotný I; Souček M
Vnitr Lek; 2017; 63(4):277-283. PubMed ID: 28520452
[TBL] [Abstract][Full Text] [Related]
15. Early pancreatic volume reduction on CT predicts relapse in patients with type 1 autoimmune pancreatitis treated with steroids.
Ohno Y; Kumagi T; Yokota T; Azemoto N; Tanaka Y; Tange K; Inada N; Miyata H; Imamura Y; Koizumi M; Kuroda T; Hiasa Y;
Orphanet J Rare Dis; 2016 Jul; 11(1):103. PubMed ID: 27465035
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic strategy for autoimmune pancreatitis.
Kamisawa T; Satake K
Adv Med Sci; 2008; 53(2):145-8. PubMed ID: 18762470
[TBL] [Abstract][Full Text] [Related]
17. Retrospective study of steroid therapy for patients with autoimmune pancreatitis in a Chinese population.
Liu B; Li J; Yan LN; Sun HR; Liu T; Zhang ZX
World J Gastroenterol; 2013 Jan; 19(4):569-74. PubMed ID: 23382638
[TBL] [Abstract][Full Text] [Related]
18. Amendment of the Japanese Consensus Guidelines for Autoimmune Pancreatitis, 2013 III. Treatment and prognosis of autoimmune pancreatitis.
Kamisawa T; Okazaki K; Kawa S; Ito T; Inui K; Irie H; Nishino T; Notohara K; Nishimori I; Tanaka S; Nishiyama T; Suda K; Shiratori K; Tanaka M; Shimosegawa T;
J Gastroenterol; 2014 Jun; 49(6):961-70. PubMed ID: 24639058
[TBL] [Abstract][Full Text] [Related]
19. Identification of relapse predictors in IgG4-related disease using multivariate analysis of clinical data at the first visit and initial treatment.
Yamamoto M; Nojima M; Takahashi H; Yokoyama Y; Ishigami K; Yajima H; Shimizu Y; Tabeya T; Matsui M; Suzuki C; Naishiro Y; Takano K; Himi T; Imai K; Shinomura Y
Rheumatology (Oxford); 2015 Jan; 54(1):45-9. PubMed ID: 24907151
[TBL] [Abstract][Full Text] [Related]
20. Analysis of Clinical, Serological, and Imaging Features of Autoimmune Pancreatitis and a Case-Control Study on Prognostic Factors in Response to Hormone Therapy.
Liu Z; Zhu K; Sun C; Shen Y; Qu S
Contrast Media Mol Imaging; 2022; 2022():4829467. PubMed ID: 35854780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
